dakshina korealo covid-19 teaca

dakshina korealo covid-19 teaca anedi desamlo konasagutunna mahammariki pratispandanagaa coronavirus vyaadhi 2019 (covid-19) kii kaaranamayye virus ayina teevramaina acute respiratory syndrome coronavirus 2 (saars-cove-2) kuu vyatiraekamgaa konasagutunna roganirodhakata pracharam.
teaca karyakramam.
korea vyaadhi niyantrana mariyu nivaarana samstha rojuvaaree naveekaranalanu andistundi.
2021 juulai 5 natiki, teaca korata kaaranamgaa, juun 20 nundi teaca raetu mandaginchabadindi. rendu vaaraalaku paiga teaca raetu 29 saatamgaa undhi. jungang ilbo prakaram, juulai 5 natiki, covid-19 vaccine yokka migilina mottam 18 laksala motaadulu, indulo 14 laksala motaadulu faizar nundi vachayi.
2021 juulai 6naa, pefizer-biontech teaca gaduvu mugisina 7,00,000 motaadulanu appuga teesukoovadaaniki dakshina korea ijraayeltho oppandam kudurchukunnatlu nivedinchabadindi. dakshina korea eee edaadi september ledhaa octoberlo adhe mottamlo teekaalanu ijraayelku tirigi istundi.
anty-virus nibandhanala sadalimpu taruvaata teevramaina kesulu mariyu maranaala sankhya peragadaaniki pratispandanagaa, covid-19 kii vyatiraekamgaa booster shaatlanu vaegamgaa andinchaalani 2021 november 29naa adhyakshudu moone jay-inn koraru.
nepathyam.
2021 fibravari 10naa, dakshina korea oxford-austrageneca covid-19 teekaaku thana modati aamodaanni manjuru chesindi, vruddhulatho sahaa peddalandarikee rendu-shaat niyamaavalini ivvadaaniki anumatinchindi. ayithe, clinical trialslo aaa janabha nundi parimita dayta kaaranamgaa 65 ellu paibadina vyaktulaku teaca ichetappudu pariganana avasaramani heccharikatho aamodam vachindi.
2021 april 14naa, adanamgaa 250,000 motaadula faizar/biontech teekaalu deshaaniki vachayi.
2021 juun 3naa, united states johnson & johnson vaccine yokka oka million motaadulanu dakshina koreaku viraalamgaa ichindi. america dalaalatoe sannihitamgaa panichestunna dakshina korea dalaalaku 550,000 motaadulanu viraalamgaa istunnatlu america modatlo prakatinchindi.
19 augustu 2021naa, romenia 450,000 gaduvu mugisina aadhunika teekaalanu dakshina koreaku viraalamgaa ivvaalani nirnayinchindi.
utpatti.
astrazeneca thana teaca utpattulanu tayaaru cheyadaaniki dakshina koreaku chendina ess. keey. bioscienceto oppandam kudurchukundi. sthaanika mariyu prapancha marketla kosam kosam nuu tayaaru cheyadaaniki essi bioscience kuu eee sahakaram pilupunistundi. prapancha aarogya samstha fibravarilo astrazeneca yokka covid-19 vaccinnu atyavasara upayogam kosam aamodinchindi. prarambha aamodam astrazeneca mariyu dakshina korea yokka ess. sii. bioscience utpatti chesina motaadulanu kaligi untundi.
dakshina koreaku chendina corus formus russiaku chendina sputnik vii covid-19 vaccinnu utpatti cheyadaaniki oka consortiumnu erpaatu chesindi. eee consortium teaca yokka 500 million motaadulanu utpatti chestundi. ayithe, dakshina korealo tayaaru cheyabadina sputnik vii motaadulu desheeya upayogam kosam kaadu. eee teekaanu russia mariyu uaelaku egumati cheyavalasi undhi.
novavax thana thana teaca saanketikatanu contract tayari prayojanaala kosam bioscience kuu licenses istundi. ske bioscience 40 million motaadula novavax teekaalanu tayaaru chestundi.
teaca prayoga dasalo undhi.
2023 janavari 9naa, ess. keey. bioscience bioscience covid-19 teaca kosam parisoedhanaatmaka kotta aushadhaanni moodava dasha clinical trial kosam korea aahara mariyu aushadha bhadrata mantritva saakhaku samarpinchindi. dakshina korealo 4,000 mandini lakshyamgaa chesukuni tulanaatmaka prabhaavavantamaina clinical trial roopamlo thana moodava dasha trialni bioscience plaan chestondi.

